BIG Congratulations to ALL, Patients and Traders Alike !!!
Dendreon (DNDN) manufactures PROVENGE, a ground-breaking vaccine for treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC). The FDA decided to approve this non-traditional vaccine today, we are extremely excited for everyone affected by this incredible news.If interested in free and ongoing technical snapshots ofDNDNvia email after this long awaited FDA approval, Click here.